Physician profile
Mitchell J Henry
NPI 1215927181
$2,328.57
in general payments reported to CMS, 2019-2025
14 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.76 · 2020: $127 · 2021: $184 · 2022: $1,158 · 2023: $188 · 2024: $429 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336 · Long Term Medical Supply Or Device Loan: $326 · Gift: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.51 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Gift | $111.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $975.40 | 2021-2022 | |
| Straumann USA LLC | $501.80 | 2022-2025 | |
| Integra Lifesciences Corporation | $376.76 | 2024 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Rti Surgical, INC | $124.68 | 2022 | |
| Acera Surgical, INC. | $108.08 | 2019-2020 | |
| Motiva USA, LLC | $63.35 | 2025 | |
| Keystone Dental INC. | $57.43 | 2020 | |
| Allergan, INC. | $29.91 | 2019-2020 | |
| Medtronic, INC. | $21.21 | 2025 | Plasmablade(Tm) |
| Vertex Pharmaceuticals Incorporated | $21.15 | 2025 | |
| Innovation Technologies INC | $15.88 | 2025 | Irrisept |
| Neurocrine Biosciences, INC. | $14.97 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.29 | 2019 | |
| Apyx Medical Corporation | $4.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.